# Heidi Health

*Last Updated: November 2025*

---

## Company Profile

| Field | Details |
|-------|---------|
| **Founded** | 2020 (rebranded 2021) |
| **Headquarters** | Melbourne, Australia |
| **Valuation** | $465 Million (Oct 2025) |
| **Total Raised** | $96.6 Million USD |
| **Scale** | 2M+ patient interactions/week |

---

## Funding History

| Round | Date | Amount | Lead Investors |
|-------|------|--------|----------------|
| Series B | Oct 2025 | $65M USD | Point72 Private Investments |
| Series A | Mar 2025 | $16.6M AUD | Headline |
| Earlier | 2020-2024 | ~$15M | Various |

### Key Investors
- Point72 Private Investments
- Blackbird Ventures (Australia)
- Headline
- Local Globe

---

## Product Overview

### Core: AI Medical Scribe
- Real-time clinical documentation
- Transcription in 110+ languages
- Structured note generation
- EHR integration (one-click)
- Auto-applies codes and tasks

### Document Types
- Clinical notes
- Referral letters
- Patient summaries
- Handouts

### Specialty Support
- General Practice (primary focus)
- Specialists
- Allied health

---

## Technology Stack

### AI/ML Approach
- Large Language Models (LLMs)
- Machine Learning for structuring
- Proprietary medical models

### Languages
- 110+ languages transcription
- Australian English optimized
- Medical terminology handling

### Infrastructure
- Cloud-native
- Australian data residency available
- Global deployment capability

---

## EHR Integrations

| EHR | Region | Status |
|-----|--------|--------|
| **Best Practice** | Australia | Deep integration |
| **Medical Director** | Australia | Integration (via Telstra Scribe) |
| **MediRecords** | Australia | Integration |
| **Gentu by Magentus** | Australia | Integration |
| **Epic** | Global | Integration |
| **athenahealth** | US | Integration |
| **Veradigm** | US | Integration |

### Australian EHR Leadership
- Deep integration with Australian GP software
- Best Practice and Medical Director are dominant in AU

### Telstra Partnership
- Powers Telstra Scribe on MedicalDirector
- Major telco partnership in Australia

---

## Customer Base

### Scale (Nov 2025)
- **2 million+ patient interactions per week**
- **100+ countries globally**
- Strong Australian market presence

### Australian Partnerships
| Partner | Details |
|---------|---------|
| GPRA | Free Heidi Pro for all GP registrars (from March 2025) |
| Hunter New England PHN | AI-Enabled GP Initiative pilot |
| Telstra Health | Powers Telstra Scribe |

### Geographic Reach
- Australia (core market)
- UK expansion
- US presence
- Global availability (100+ countries)

---

## Regulatory & Compliance

| Framework | Status |
|-----------|--------|
| **Australian Privacy Principles** | Compliant |
| **ISO 27001** | Certified |
| **SOC 2 Type II** | Certified |
| **HIPAA** | Compliant (US) |
| **GDPR** | Compliant (EU) |
| **NHS regulations** | Compliant (UK) |
| **PIPEDA** | Compliant (Canada) |

### TGA Status
- Software as Medical Device considerations
- Compliance with Australian regulatory framework

### Data Residency
- Australian data storage available
- Compliant with local data sovereignty requirements

---

## Pricing

| Tier | Details |
|------|---------|
| Heidi Free | Basic features |
| Heidi Pro | Full features, subscription |
| Enterprise | Custom pricing |

*Australian pricing competitive with local market*

---

## Clinical Outcomes

### KLAS Recognition (2025)
- US healthcare organizations cited:
  - Reduced clinician documentation time
  - Improved note accuracy
- Areas for improvement: EHR integration depth

---

## Strengths

1. **Australian market leader** - Deep local presence
2. **Australian EHR integrations** - Best Practice, Medical Director
3. **Multi-language** - 110+ languages
4. **Regulatory compliance** - Full Australian compliance
5. **Telstra partnership** - Major local distribution
6. **GP focus** - Primary care expertise
7. **Rapid growth** - 2M+ interactions/week
8. **Global expansion** - UK, US presence

---

## Weaknesses

1. **Enterprise scale** - Less proven at large health system level
2. **Hospital focus** - Primarily GP/clinic focused
3. **Specialty depth** - Less specialized than some competitors
4. **Beyond-the-note** - Less developed than Abridge/Nabla
5. **US competition** - Crowded market against well-funded players

---

## Competitive Positioning

### vs US Vendors (Nuance, Abridge)
- Heidi stronger in Australia
- US vendors have more enterprise features
- Heidi more affordable for SMB

### vs Nabla
- Both have international presence
- Nabla more enterprise-focused
- Heidi stronger Australian local presence

### Australian Market
- Leading local AI scribe vendor
- Competition from US vendors entering AU

---

## Relevance for Ramsay Health Care

### HIGHLY RELEVANT for Australian Operations

#### Pros
1. **Local presence** - Melbourne HQ, understands AU healthcare
2. **Australian EHRs** - Deep integrations with AU clinical software
3. **Regulatory** - Full Australian compliance
4. **Support** - Local support in Australian time zones
5. **Pricing** - AUD pricing, no FX complexity
6. **GPRA partnership** - Demonstrates AU healthcare credibility
7. **Telstra relationship** - Enterprise-grade partnerships

#### Cons
1. **Hospital scale** - Less proven at Ramsay's hospital scale
2. **Beyond-the-note** - CDI, coding less developed
3. **Non-AU regions** - Less relevant for UK, France, Nordics
4. **Specialty mix** - GP focus vs Ramsay's surgical specialty

### Ramsay Fit by Region
| Region | Heidi Fit |
|--------|-----------|
| Australia | Excellent (local leader) |
| UK | Moderate (expanding) |
| France | Limited (Nabla better fit) |
| Nordics | Limited |
| Asia | Moderate (language support) |

---

## 2025-2026 Outlook

- Continued Australian market leadership
- UK expansion acceleration
- Enterprise/hospital capability development
- Potential acquisition target for US vendors
- Series C likely given growth

---

## Sources

- heidihealth.com
- Healthcare Innovation Group coverage
- Mobi Health News
- GPRA partnership announcement
- Tracxn company profile
- Wikipedia

---

*Analysis by Alex Stinard, MD | Healthcare AI Vendor Analysis Project*
